Detalles de la búsqueda
1.
Association between choice of reversal agent for neuromuscular block and postoperative pulmonary complications in patients at increased risk undergoing non-emergency surgery: STIL-STRONGER, a multicentre matched cohort study.
Br J Anaesth
; 130(1): e148-e159, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35691703
2.
Neuromuscular Blockade and Reversal Practice Variability in the Outpatient Setting: Insights From US Utilization Patterns.
Anesth Analg
; 133(6): 1437-1450, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34784330
3.
Neuromuscular Blocking Agents and Reversal Agents Among Hospitalized Children: A Cerner Database Study.
Hosp Pharm
; 56(5): 424-429, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34720141
4.
Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): A Multicenter Matched Cohort Analysis.
Anesthesiology
; 132(6): 1371-1381, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32282427
5.
The impact of intra-abdominal pressure on perioperative outcomes in laparoscopic cholecystectomy: a systematic review and network meta-analysis of randomized controlled trials.
Surg Endosc
; 34(7): 2878-2890, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32253560
6.
Post-operative urinary retention is impacted by neuromuscular block reversal agent choice: A retrospective cohort study in US hospital setting.
J Clin Anesth
; 93: 111344, 2024 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38007845
7.
Trends in the use of neuromuscular blocking agents, reversal agents and neuromuscular transmission monitoring: a single-centre retrospective cohort study.
Perioper Med (Lond)
; 13(1): 22, 2024 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38539254
8.
Contemporary outpatient management of patients with worsening heart failure with reduced ejection fraction: Clinical outcome results from the CHART-HF study.
Int J Cardiol Cardiovasc Risk Prev
; 21: 200278, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38766664
9.
Treatment patterns of patients with worsening heart failure with reduced ejection fraction.
ESC Heart Fail
; 2024 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38639469
10.
REVersal of nEuromusculAr bLocking Agents in Patients Undergoing General Anaesthesia (REVEAL Study).
J Clin Med
; 12(2)2023 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36675492
11.
Systematic review and meta-analysis of the efficacy of cardioversion by vernakalant and comparators in patients with atrial fibrillation.
Cardiovasc Drugs Ther
; 26(2): 167-79, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22418856
12.
RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers.
BMC Cardiovasc Disord
; 12: 85, 2012 Oct 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-23031215
13.
The Use of Muscle Relaxants and Reversal Agents in a Setting Without Cost Restrictions: Experience from a Tertiary Academic Hospital in the Netherlands.
Ther Clin Risk Manag
; 18: 379-390, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35422624
14.
Race differences in access to health care and disparities in incident chronic kidney disease in the US.
Nephrol Dial Transplant
; 26(3): 899-908, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20688771
15.
Albuminuria and estimated glomerular filtration rate independently associate with acute kidney injury.
J Am Soc Nephrol
; 21(10): 1757-64, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20671214
16.
Heart rate variability predicts ESRD and CKD-related hospitalization.
J Am Soc Nephrol
; 21(9): 1560-70, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20616169
17.
A Clinical and Budgetary Impact Analysis of Introducing Sugammadex for Routine Reversal of Neuromuscular Blockade in a Hypothetical Cohort in the US.
Adv Ther
; 38(5): 2689-2708, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33871823
18.
Neuromuscular Blockade and Reversal Agent Practice Variability in the US Inpatient Surgical Settings.
Adv Ther
; 38(9): 4736-4755, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34319550
19.
Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study.
Am J Kidney Dis
; 55(1): 31-41, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19932544
20.
Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study.
Am J Kidney Dis
; 55(4): 648-59, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20189275